Explaining differences in the frequency of lung cancer detection between the National Lung Screening Trial and community-based screening in Manchester, UK is a research paper published in Lung Cancer (2022). On theSindex it has a DataRank of 0. It has been cited 8 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph β no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full β never from an abstract alone.
Manchester Biomedical Research Centre
Grant: IS-BRC-1215-20007
National Cancer Institute
Grant: R03 CA245979
National Cancer Institute
Grant: NCI U19 CA203654
NCI NIH HHS
Grant: U19 CA203654
World Health Organization
Grant: 001
National Institute for Health Research (NIHR)
Grant: NIHR-INF-0571
Intramural NIH HHS
Grant: Z99 CA999999
National Institute for Health Research (NIHR)
Grant: NIHR300650
National Institute for Health and Care Research
National Institutes of Health
FWCI
0.82
Citation Percentile
0.7%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals